Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-06-05
1980-10-21
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260396R, 424251, 424263, 424304, 424311, 424320, A61K 3112
Patent
active
042294789
ABSTRACT:
Psoriasis in mammals is relieved by topically administering substituted naphthaquinones of the formula: ##STR1## where R.sup.1 and R.sup.2 are the same or different and are hydrogen, hydroxy, alkoxy or acylamino and R.sup.3 is hydrogen, halo, cyano or alkoxy with the proviso that R.sup.1 and R.sup.2 are not both hydrogen.
REFERENCES:
patent: 3914264 (1975-10-01), Marsico et al.
Chemical Abstracts 52:10211 (1958).
Jones Gordon H.
Young John
Krubiner Alan M.
Moran Tom M.
Schenkman Leonard
Syntex (U.S.A.) Inc.
LandOfFree
Naphthaquinone anti-psoriatic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthaquinone anti-psoriatic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthaquinone anti-psoriatic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2022995